This shift was demonstrated in vitro through direct observations of bacterial survival under mixed bacterial culture conditions in the presence of the human cathelicidin LL-37, observed on the skin of patients with atopic dermatitis, and further demonstrated on mice. Here, CAMP is linked to atopic eczema.